NCT07049562View on ClinicalTrials.gov

Study on the Mass Balance of [14C]HRS-8427 for Injection in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

June 18, 2025

Study Completion Date

June 18, 2025

Conditions
Healthy Cninese Adult Male
Interventions
DRUG

HRS-8427

\[14C\] HRS-8427 for injection

Trial Locations (1)

250014

First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY